Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Immunome Inc IMNM

Healthcare Biotechnology
Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugates (ADCs). Its memory B cell hybridoma technology allows for the screening and functional characterization of novel antibodies and targets. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IMNM)

Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire 8 days ago

Immunome to Present at Guggenheim's Inaugural Healthcare Innovation Conference

Business Wire November 5, 2024

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 1, 2024

Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021

Business Wire October 29, 2024

Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium

Business Wire October 18, 2024

Immunome Appoints Roee Shahar as Executive Vice President, Commercial

Business Wire October 8, 2024

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 8, 2024

Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024

Business Wire September 13, 2024

Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Business Wire August 29, 2024
View More News ››

Opinion & Analysis (NDAQ:IMNM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:IMNM)

Immunome to Present Updated Results for RINGSIDE Phase 2 Tri

JUST IN: $IMNM Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the...
whytestocks - September 13, 2024

Long Term Trading Analysis for (IMNM)

Breaking News: $IMNM Long Term Trading Analysis for (IMNM)2024-08-13 01:34:00 ET Stock Traders Daily has produced this trading report...
whytestocks - August 13, 2024

Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks I

Just In: $IMNM Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying | BenzingaAlthough U.S. stocks closed...
whytestocks - May 22, 2024

CAN IMMUNOME BOUNCE BACK FROM CLINICAL HOLD ON IMM-BCP-01

$IMNM   Immunome, Inc. (NASDAQ: IMNM), a biopharmaceutical company, announced the receipt of a clinical hold letter from the U...
AviseAnalytics - January 17, 2022
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. provides contract drilling services, primarily to the oil and gas industry, in Canada and the United ...
View More »